October 4, 2016
Bayer Yakuhin began a voluntary recall of its hemophilia A treatment Kogenate (octocog alfa) on October 3 after some lots showed a tendency of faster-than-expected potency losses before their shelf life expiry. Subject to the recall are 31 lots of...read more